Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies-Reference-Cited by-同舟云学术

Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies

Published:2018-04-16 Issue:4 Volume:9 Page:715-726
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:Journal of Cachexia, Sarcopenia and Muscle

Author:

Spitali Pietro¹^ORCID,Hettne Kristina¹,Tsonaka Roula²,Charrout Mohammed¹,van den Bergen Janneke³,Koeks Zaïda³,Kan Hermien E.⁴,Hooijmans Melissa T.⁴,Roos Andreas⁵,Straub Volker⁵,Muntoni Francesco⁶,Al-Khalili-Szigyarto Cristina⁷,Koel-Simmelink Marleen J.A.⁸,Teunissen Charlotte E.⁸,Lochmüller Hanns⁵,Niks Erik H.³,Aartsma-Rus Annemieke¹⁴

Affiliation:

1. Department of Human Genetics; Leiden University Medical Center; Leiden The Netherlands

2. Department of Medical Statistics and Bioinformatics; Leiden University Medical Center; Leiden The Netherlands

3. Department of Neurology; Leiden University Medical Center; Leiden The Netherlands

4. C.J. Gorter Center for High Field MRI, Department of Radiology; Leiden University Medical Center; Leiden The Netherlands

5. John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine; University of Newcastle; Newcastle upon Tyne UK

6. Dubowitz Neuromuscular Centre; University College London Great Ormond Street Institute of Child Health; London UK

7. Division of Proteomics, School of Biotechnology; KTH-Royal Institute of Technology; Stockholm Sweden

8. Neurochemistry Lab and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience; VU University Medical Center Amsterdam; The Netherlands

Funder

Parent Project Muscular Dystrophy

ZonMw

the Association Française contre les Myopathies

Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases (NEUROMICS)

the European Community's Seventh Framework Programme

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcsm.12304/fullpdf

Reference47 articles.

1. Diagnosis and new treatments in muscular dystrophies;Manzur;J Neurol Neurosurg Psychiatry,2009

2. 195th ENMC International Workshop: newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands;Ellis;Neuromuscul Disord,2013

3. Dystrophin is a microtubule-associated protein;Prins;J Cell Biol,2009

4. Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin;Way;FEBS Lett,1992

5. 204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands;Ferlini;Neuromuscul Disord,2015

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy;2024-08-07

2. Physiology of malate dehydrogenase and how dysregulation leads to disease;Essays in Biochemistry;2024-07-04

3. Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling;Molecular Aspects of Medicine;2024-06

4. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

5. How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?;Proteomes;2024-01-16